Lilly(Eli) & Company
NYSE: LLY
$774.56
Real Time Data Delayed 15 Min.
LLY Articles
ETFs and mutual funds can both be powerful tools for investors seeking diversification. Both of these investment vehicles hold baskets of securities. When you purchase them, you’re also purchasing...
Published:
SCHD and VOO are two very popular ETFs for investors looking to diversify quickly. Like all ETFs, these two investment vehicles hold a “bucket” of stocks. However, the stocks they hold are very...
Published:
ETFs are a great way for investors to get instant diversification at a low cost. But with so many ETFs available, choosing the right one for your investment goals can be daunting. In this article,...
Published:
Imagine buying a stock for 24 cents, and one day opening your brokerage account to see eye-popping returns of 55,919%. Your stock is now worth $133. Sound like a fairy tale? It isn’t. Today I’ll...
Published:
The pharmaceutical sector is one that has gone from decades of heavy investment, high growth, and consolidation to a maturing space with a few key players that have more recently provided much more...
Published:
24/7 Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat analysts’ forecasts and prospered accordingly. In 5 Years, Eli Lilly has...
Published:
In the movie The Social Network, there’s a scene where the investor Sean Parker is trying to sweet talk Mark Zuckerberg and says “A million dollars isn’t cool… You know what’s cool?”...
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
The exclusive trillion-dollar club currently has five American members — Apple (NASDAQ: AAPL) at around $3 trillion market capitalization, Microsoft at about $2.8 trillion, Google parent Alphabet...
Published:
Here are some of the top upgrades, downgrades and other analyst calls for Thursday, December 21, along with other investing news.
Published:
Thursday's top analyst upgrades and downgrades included Bumble, Coupang, Datadog, Dish Network, DraftKings, Eli Lilly, International Flavors & Fragrances, LivePerson, Novavax, Nvidia, Qualcomm and...
Published:
Thursday's top analyst upgrades and downgrades included Alphabet, Eli Lilly, Etsy, Microsoft, Mosaic, NetApp, Omega Healthcare Investors, RTX, Sherwin-Williams, Spotify Technology, Walt Disney and WW...
Published:
Monday's top analyst upgrades and downgrades included Amazon.com, AT&T, Broadcom, Corning, DraftKings, Eli Lilly, Fortinet, General Mills, Leslie’s, Microsoft, Nvidia, Plug Power, Progressive,...
Published:
Thursday's top analyst upgrades and downgrades included Antero Resources, AutoZone, Coterra Energy, Dollar General, Eli Lilly, First Horizon, Infosys, Owens Corning, Palo Alto Networks, Range...
Published:
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Published: